On April 22, Partners Lachlan Campbell-Verduyn and Andrew D. Cohen will speak at the American Conference Institute's 2026 Paragraph IV Disputes Conference, the preeminent forum for pharmaceutical patent litigation.

At 9:45am, Dr. Campbell-Verduyn will speak on a panel titled "Avoiding Costly Conception and Inventorship Missteps in Pharmaceutical Patent Cases." With Tom Irving and Jonathan James Underwood, she will discuss recent cases and best practices around questions of inventorship and conception.

At 3:30pm, Dr. Cohen will speak on a program titled "Promise and Peril for Patents: Navigating Mandated Disclosures and Prior Art Pitfalls." He will join Angie Verrecchio (Senior Counsel, Patent Litigation, Johnson & Johnson), Ryan Johnson, and Ricardo Camposanto to explore whether or not clinical trials and disclosures of information are prior art, how such disclosures are used by patent challengers, and innovator mitigation strategies.

To learn more, please click here.